Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$215K Sell
684
-112
-14% -$35.3K 0.01% 465
2026
Q1
$261K Buy
796
+27
+4% +$9.69K 0.01% 367
2025
Q4
$270K Buy
769
+8
+1% +$2.92K 0.01% 343
2025
Q3
$281K Buy
761
+98
+15% +$37.9K 0.01% 318
2025
Q2
$262K Buy
663
+35
+6% +$13.1K 0.01% 315
2025
Q1
$234K Sell
628
-194
-24% -$73.8K 0.01% 301
2024
Q4
$296K Buy
822
+56
+7% +$20.8K 0.02% 279
2024
Q3
$277K Buy
766
+81
+12% +$28K 0.02% 270
2024
Q2
$233K Sell
685
-2
-0.3% -$677 0.01% 278
2024
Q1
$246K Sell
687
-37
-5% -$12.4K 0.02% 258
2023
Q4
$217K Buy
+724
New +$203K 0.02% 257

Other funds holding SYK

McAdam LLC's SYK Position: Q2 2026 in Review

McAdam LLC reduced its Stryker (SYK) stake by 14% in Q2 2026, selling an estimated $35.3K and leaving 684 shares worth $215K. The position accounts for 0.01% of the portfolio, ranked #465.

McAdam LLC first reported a position in SYK in Q4 2023 and has held it in 11 quarters since. The position peaked at $296K in Q4 2024. 2,267 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • McAdam LLC held 684 shares of Stryker worth $215K as of Q2 2026.
  • McAdam LLC sold 112 Stryker shares in Q2 2026, an estimated $35.3K.
  • Stryker made up 0.01% of McAdam LLC's portfolio in Q2 2026, its #465 holding.
  • McAdam LLC first reported a position in Stryker in Q4 2023 and has held it in 11 quarters since.
  • McAdam LLC's Stryker position peaked at $296K in Q4 2024.
  • 2,267 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on McAdam LLC's 13F filing for Q2 2026, filed 4 Aug 2026.